| 面向发展中国家新药研发的PPP模式与运行机制分析 |
| |
| 引用本文： | 郑晓南,黄文龙.面向发展中国家新药研发的PPP模式与运行机制分析[J].科技与经济,2010,23(4):82-85. |
| |
| 作者姓名： | 郑晓南 黄文龙 |
| |
| 作者单位： | 中国药科大学,南京,210009 |
| |
| 摘 要： | 介绍国际组织为了加强发展中国家"被忽视疾病"的新药研发,导入公私合作伙伴关系(Public—Private—Partnership,PPP)模式的特征与优势,分析了"被忽视疾病"新药研发的动力机制与内涵:探讨了PPP模式运行机制、融资模式与组织模式。将PPP模式与我国基本药物供应保障体系相联系,以期对我国重大科技专项起到借鉴作用。
|
| 关 键 词： | 发展中国家 公私合作伙伴关系（PPP） 被忽视疾病（ND） 新药研发 模式 运行机制 |
Analysis of PPP Model and Its Operation Mechanism on New Drugs R&D of Neglected Diseases for Developing Countries |
| |
| ZHENG Xiao-nan,HUANG Wen-long.Analysis of PPP Model and Its Operation Mechanism on New Drugs R&D of Neglected Diseases for Developing Countries[J].Science & Technology and Economy,2010,23(4):82-85. |
| |
| Authors: | ZHENG Xiao-nan HUANG Wen-long |
| |
| Institution: | (China Pharmaceutical University, Nanjing 210009, China) |
| |
| Abstract: | The public private partnership model is introduced to strengthen the new drugs research of Neglected diseases for developing countries by international organizations. This paper introduces the characteristics and advantages of Public Private Partnership model, makes an analysis of its motivation mechanism and connotation and discusses its operation mechanism , financing and organization modes, which will give reference to essential drugs supply guarantee system and major national science and technology in China. |
| |
| Keywords: | developing country PPP neglected diseases new drugs R＆D model operation mechanism |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《科技与经济》浏览原始摘要信息 |
| 点击此处可从《科技与经济》下载免费的PDF全文 |
